ID

37863

Description

Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01153282

Lien

https://clinicaltrials.gov/show/NCT01153282

Mots-clés

Versions (2)
  1. 28/08/2019 28/08/2019 -
  2. 28/08/2019 28/08/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 août 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT01153282

Anglais

Eligibility Breast Cancer NCT01153282

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
women 21-70 years old (women over 70 are offered chemotherapy less frequently because of their risk benefit ratio. including them would be a selection bias because of their differential underexposure).
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
initiated taxane-based chemotherapy in the neoadjuvant, adjuvant, or previously untreated metastatic setting.
Description

Taxane | Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant | Neoplasm Metastasis Untreated

Type de données

boolean

Alias
UMLS CUI [1]
C0215136
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C3665472
UMLS CUI [3]
C0085533
UMLS CUI [4,1]
C0027627
UMLS CUI [4,2]
C0332155
the range of exposure to taxane-based chemotherapy will include women on active treatment having received two cycles, to women who are within three months of their last infusion.
Description

Exposure to Taxane Chemotherapy | Chemotherapy cycle Quantity | Timespan Infusion Last

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0215136
UMLS CUI [1,3]
C3665472
UMLS CUI [2,1]
C1302181
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C0872291
UMLS CUI [3,2]
C0574032
UMLS CUI [3,3]
C1517741
documented symptoms of cipn per ctcae grading criteria (half of sample) or no symptoms (half of sample) grade 0 = no cipn symptoms grade 1 = mild symptoms grade 2 = moderate symptoms - prescribed gabapentin (neurontin) grade 3&4= severe symptoms -
Description

Symptoms Chemotherapy-induced peripheral neuropathy CTCAE Grades | Symptoms Absent | gabapentin | Neurontin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C3873567
UMLS CUI [1,3]
C1516728
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0060926
UMLS CUI [4]
C0678176
treated with gabapentin (neurontin), treatment plan altered
Description

Gabapentin | Neurontin | Treatment Plan altered

Type de données

boolean

Alias
UMLS CUI [1]
C0060926
UMLS CUI [2]
C0678176
UMLS CUI [3,1]
C0599880
UMLS CUI [3,2]
C0392747
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
physical disabilities - defined by use of assistive devices to complete functional tasks (wheelchair, crutches, prosthetic limbs) prior to starting chemotherapy.
Description

Physical disability | Use of Assistive Devices | Wheelchair | Crutches | Limb Prosthesis

Type de données

boolean

Alias
UMLS CUI [1]
C0520817
UMLS CUI [2,1]
C1524063
UMLS CUI [2,2]
C0036605
UMLS CUI [3]
C0043143
UMLS CUI [4]
C0010397
UMLS CUI [5]
C0347948
current exposure to neurotoxic agents (navelbine, platinums or other taxanes)
Description

Exposure to Neurotoxic agents | Navelbine | Platinum | Taxanes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0260049
UMLS CUI [2]
C0131965
UMLS CUI [3]
C0032207
UMLS CUI [4]
C0796419
pregnancy during chemotherapy treatment
Description

Pregnancy During Chemotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0392920
diabetes - diagnosed 3 or more years , or insulin dependent, or with clinically established neuropathy
Description

Diabetes Mellitus Disease length | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus With Neuropathy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0872146
UMLS CUI [2]
C0011854
UMLS CUI [3,1]
C0011849
UMLS CUI [3,2]
C0332287
UMLS CUI [3,3]
C0442874
previous exposure to chemotherapy or radiotherapy
Description

Exposure to Chemotherapy | Exposure to Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0392920
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C1522449
hiv positive (high risk for neuropathy)
Description

HIV Seropositivity | High risk of Neuropathy

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2,1]
C0332167
UMLS CUI [2,2]
C0442874
other neurological diseases, such as multiple sclerosis
Description

Nervous system disorder | Multiple Sclerosis

Type de données

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0026769
other pre-existing neuropathy
Description

Neuropathy Pre-existing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C2347662
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT01153282

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
women 21-70 years old (women over 70 are offered chemotherapy less frequently because of their risk benefit ratio. including them would be a selection bias because of their differential underexposure).
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Taxane | Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant | Neoplasm Metastasis Untreated
Item
initiated taxane-based chemotherapy in the neoadjuvant, adjuvant, or previously untreated metastatic setting.
boolean
C0215136 (UMLS CUI [1])
C0600558 (UMLS CUI [2,1])
C3665472 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3])
C0027627 (UMLS CUI [4,1])
C0332155 (UMLS CUI [4,2])
Exposure to Taxane Chemotherapy | Chemotherapy cycle Quantity | Timespan Infusion Last
Item
the range of exposure to taxane-based chemotherapy will include women on active treatment having received two cycles, to women who are within three months of their last infusion.
boolean
C0332157 (UMLS CUI [1,1])
C0215136 (UMLS CUI [1,2])
C3665472 (UMLS CUI [1,3])
C1302181 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0872291 (UMLS CUI [3,1])
C0574032 (UMLS CUI [3,2])
C1517741 (UMLS CUI [3,3])
Symptoms Chemotherapy-induced peripheral neuropathy CTCAE Grades | Symptoms Absent | gabapentin | Neurontin
Item
documented symptoms of cipn per ctcae grading criteria (half of sample) or no symptoms (half of sample) grade 0 = no cipn symptoms grade 1 = mild symptoms grade 2 = moderate symptoms - prescribed gabapentin (neurontin) grade 3&4= severe symptoms -
boolean
C1457887 (UMLS CUI [1,1])
C3873567 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C1457887 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0060926 (UMLS CUI [3])
C0678176 (UMLS CUI [4])
Gabapentin | Neurontin | Treatment Plan altered
Item
treated with gabapentin (neurontin), treatment plan altered
boolean
C0060926 (UMLS CUI [1])
C0678176 (UMLS CUI [2])
C0599880 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Physical disability | Use of Assistive Devices | Wheelchair | Crutches | Limb Prosthesis
Item
physical disabilities - defined by use of assistive devices to complete functional tasks (wheelchair, crutches, prosthetic limbs) prior to starting chemotherapy.
boolean
C0520817 (UMLS CUI [1])
C1524063 (UMLS CUI [2,1])
C0036605 (UMLS CUI [2,2])
C0043143 (UMLS CUI [3])
C0010397 (UMLS CUI [4])
C0347948 (UMLS CUI [5])
Exposure to Neurotoxic agents | Navelbine | Platinum | Taxanes
Item
current exposure to neurotoxic agents (navelbine, platinums or other taxanes)
boolean
C0332157 (UMLS CUI [1,1])
C0260049 (UMLS CUI [1,2])
C0131965 (UMLS CUI [2])
C0032207 (UMLS CUI [3])
C0796419 (UMLS CUI [4])
Pregnancy During Chemotherapy
Item
pregnancy during chemotherapy treatment
boolean
C0032961 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Diabetes Mellitus Disease length | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus With Neuropathy
Item
diabetes - diagnosed 3 or more years , or insulin dependent, or with clinically established neuropathy
boolean
C0011849 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0011854 (UMLS CUI [2])
C0011849 (UMLS CUI [3,1])
C0332287 (UMLS CUI [3,2])
C0442874 (UMLS CUI [3,3])
Exposure to Chemotherapy | Exposure to Therapeutic radiology procedure
Item
previous exposure to chemotherapy or radiotherapy
boolean
C0332157 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
HIV Seropositivity | High risk of Neuropathy
Item
hiv positive (high risk for neuropathy)
boolean
C0019699 (UMLS CUI [1])
C0332167 (UMLS CUI [2,1])
C0442874 (UMLS CUI [2,2])
Nervous system disorder | Multiple Sclerosis
Item
other neurological diseases, such as multiple sclerosis
boolean
C0027765 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
Neuropathy Pre-existing
Item
other pre-existing neuropathy
boolean
C0442874 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial